Investigational Site Number : 1240003

Hamilton, Ontario L8N 4A6

2 studies enrolling now · 4 studies all time

What they study most

Alopecia Areata, Asthma, Factor VIII Deficiency

Studies at this site

• Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy — Recruiting now
• Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma — Enrolling by invitation
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata — Stopped early
• Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma — Completed